QUAISAR DRUG DESIGN PLATFORM
Mark Identification

QUAISAR DRUG DESIGN PLATFORM

Serial Number

97760513

Filing Date

Jan 19, 2023

Trademark by

PSIVANT THERAPEUTICS INC.

Classification Information

Downloadable and recorded computer software for providing, analyzing and generating reports; downloadable and recorded computer software for data processing; electronic apparatus, electronic equipment, downloadable and recorded software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable and recorded computer software for database integration; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for genetic assessment and identification of diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical data and images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Electrical and Scientific Apparatus

Scientific and technological services and research and design in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; analyzing of technical scientific and pharmaceutical research data by computers; Pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; drug discovery services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; analyzing scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; bioinformatics services, namely, using the combination of biology, computer science, information engineering, mathematics and statistics to analyse and interpret biological data; computer assisted molecule design; scientific and biological research, namely, identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer aided diagnostic for scientific research purposes; computer aided scientific screening services for scientific research purposes; contract scientific research services in support of scientific research and development of pharmaceutical preparations; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Computer and Scientific